Jeffrey Ravetch describes how he came to identify the in vivo function of the once mysterious Fc receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berken, et al. J. Exp. Med. 123, 119–144 (1966).
Ravetch, J.V. in Fundamental Immunology 5th edn. (ed. Paul, W.) (Lippincott-Raven, Philadelphia-New York, 2003).
Nimmerjahn, et al. Nat. Rev. Immunol. 8, 34–47 (2008).
Nimmerjahn, et al. Curr. Opin. Immunol. 19, 239–245 (2007).
Hessell, et al. Nature 449, 101–104 (2007).
Verma, et al. Clin. Vaccine Immunol. 16, 1405–1412 (2009).
Janeway, C.A. in Immunobiology 1st edn. (Elsevier, New York, 1994).
Janeway, C.A. in Immunobiology 4th edn. (Elsevier, New York, 1999).
Ravetch, et al. Cell 27, 583–591 (1981).
Ravetch, et al. Proc. Natl. Acad. Sci. USA 77, 6734–6738 (1980).
Unkeless, J.C. J. Exp. Med. 150, 580–596 (1979).
Ravetch, et al. Science 234, 718–725 (1986).
Qiu, et al. Science 248, 732–735 (1990).
Kurosaki, et al. Nature 342, 805–807 (1989).
Muta, et al. Nature 369, 340 (1994).
Ravetch, et al. Science 290, 84–89 (2000).
Nimmerjahn, et al. Immunity 23, 41–51 (2005).
Takai, et al. Cell 76, 519–529 (1994).
Arthus, M. Seances et Memoire de la Societe de Biologie 55, 817 (1903).
Sylvestre, et al. Science 265, 1095–1098 (1994).
Wessels, et al. Proc. Natl. Acad. Sci. USA 92, 11490–11494 (1995).
Sylvestre, et al. J. Exp. Med. 184, 2385–2392 (1996).
Clynes, et al. Science 279, 1052–1054 (1998).
Podolanczuk, et al. Blood 113, 3154–3160 (2009).
Weinblatt, et al. Arthritis Rheum. 58, 3309–3318 (2008).
Clynes, et al. Nat. Med. 6, 443–446 (2000).
Cartron, et al. Blood 99, 754–758 (2002).
Musolino, et al. J. Clin. Oncol. 26, 1789–1796 (2008).
Takai, et al. Nature 379, 346–349 (1996).
Bolland, et al. Immunity 13, 277–285 (2000).
McGaha, et al. Science 307, 590–593 (2005).
Tsuchiya, et al. Autoimmunity 38, 347–352 (2005).
Mackay, et al. J. Exp. Med. 203, 2157–2164 (2006).
Anthony, et al. Proc. Natl. Acad. Sci. USA 105, 19571–19578 (2008).
Kaneko, et al. Science 313, 670–673 (2006).
Acknowledgements
I thank all the students, postdoctoral fellows, technicians and administrative staff who have worked with me over the past 25 years to investigate the complexities of the Fc receptor system, whose insights, hard work and dedication have been invaluable; my colleagues at The Rockefeller University, R. Steinman and M. Nussenzweig, who have been advisors, collaborators; and loyal friends who have made the pursuit of science such a delight. The financial support provided by the National Institutes of Health, donors and philanthropists has allowed this work to progress to the point it has reached today; it is only with their continued support that we can hope to translate this basic work into practical therapies in the future.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ravetch, J. In vivo veritas: the surprising roles of Fc receptors in immunity. Nat Immunol 11, 183–185 (2010). https://doi.org/10.1038/ni0310-183
Issue Date:
DOI: https://doi.org/10.1038/ni0310-183
This article is cited by
-
Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine
Drugs (2018)
-
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
Nature Reviews Drug Discovery (2012)
-
Antibody therapy of cancer
Nature Reviews Cancer (2012)
-
Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective
Critical Care (2011)
-
Immunity and immunopathology to viruses: what decides the outcome?
Nature Reviews Immunology (2010)